FDA approves melphalan as a liver-directed treatment for uveal melanoma

On August 14, 2023, the Food and Drug Administration approved HEPZATO KIT (melphalan for Injection/Hepatic Delivery System) containing melphalan (HEPZATO, Delcath Systems, Inc.)

Source: FDA Center for Drug Evaluation and Research - What's New - August 15, 2023 Category: Drugs & Pharmacology Authors: FDA Source Type: news